[ALNY] QoQ Quarter Result on 31-Mar-2012 [#Q1]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
03-May-2012
Financial Year
2012
Quarter
31-Mar-2012 [#Q1]
Profit Trend
QoQ- 20.52%
YoY- 30.19%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Revenue 8,495 16,759 20,884 20,587 20,455 20,791 20,614 -44.47%
PBT -72,760 -19,502 -12,956 -11,368 -14,303 -13,237 -13,824 201.06%
Tax -10,572 -2,543 -2,855 -414 -237 -930 -1,593 251.13%
NP -62,188 -19,502 -12,956 -11,368 -14,303 -13,237 -13,824 171.27%
Tax Rate - - - - - - - -
Total Cost 70,683 36,261 33,840 31,955 34,758 34,028 34,438 61.15%
Ratio Analysis
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
NP Margin -732.05 -116.37 -62.04 -55.22 -69.92 -63.67 -67.06 388.54%
Per Share
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
EPS -1.20 -0.38 -0.25 -0.25 -0.31 -0.31 -0.33 135.54%
EPS Diluted -1.20 -0.38 -0.25 -0.25 -0.31 -0.31 -0.33 135.54%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.